Angela McLean, MD
Internal Medicine · New Orleans, LANPI 1578585345
Payments from drug & device makers
Across 16 payments — averaging $160.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2K
- Johnson & Johnson$116
- Greenwich Biosciences, Inc.$62
- Eisai Inc.$39
- Boehringer Ingelheim$26
- Novartis$21
- plus $92 from 6 others
What the payments were for
- Consulting fees$2,21986%
- Food & beverage$34013%
- Education$151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1 | $2,219 |
| Johnson & Johnson | 3 | $116 |
| Greenwich Biosciences, Inc. | 1 | $62 |
| Eisai Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $26 |
| Novartis | 1 | $21 |
| Indivior Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| UCB, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| GSK | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mResvia$2,219
How this compares
$2,573 in reported general payments places this provider in the 75th percentile of 1,528 internal medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $18,525 |
| Candesartan Cilexetil | 16 | $1,349 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $928 |
| Amlodipine Besylate | 114 | $687 |
| Losartan Potassium | 60 | $561 |
| Atorvastatin Calcium | 76 | $559 |
| Gabapentin | 28 | $501 |
| Omeprazole | 18 | $407 |
| Hydrocortisone | 13 | $352 |
| Pravastatin Sodium | 42 | $332 |
| Metoprolol Succinate | 42 | $278 |
| Levothyroxine Sodium | 45 | $268 |
| Lisinopril | 36 | $205 |
| Fluticasone Propionate | 12 | $198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $173 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New Orleans
- William SmithNew Orleans$50.5M
- Brian LewisNew Orleans$2M
- Steven DeitelzweigNew Orleans$939K
- Lydia BazzanoNew Orleans$892K
- Eboni Price-HaywoodNew Orleans$659K
- Susan Lewis AbdalianNew Orleans$301K
- Eduardo RodriguezNew Orleans$167K
- Shigeki SaitoNew Orleans$120K
- Jonathan GugelNew Orleans$95K
- Keith WinfreyNew Orleans$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.